CPMV (Mosaic ImmunoEngineering) 5-Year Yield-on-Cost %: 0.00 (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Mosaic ImmunoEngineering 5-Year Yield-on-Cost %?

Mosaic ImmunoEngineering CPMV +11.11% 5-Year Yield-on-Cost % is 0.00 as of Aug. 01, 2026. The stock has 2 warning signs investors should review. Among 150 Biotechnology companies, Mosaic ImmunoEngineering ranks worse than 666666% on this metric.

Mosaic ImmunoEngineering's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Mosaic ImmunoEngineering's 5-Year Yield-on-Cost % or its related term are showing as below:



CPMV's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.71
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Mosaic ImmunoEngineering  (OTCPK:CPMV) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Mosaic ImmunoEngineering 5-Year Yield-on-Cost % Related Terms

CPMV vs TCRT, JAGX, BGMS: 5-Year Yield-on-Cost % Comparison

For the Biotechnology subindustry, Mosaic ImmunoEngineering's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mosaic ImmunoEngineering 5-Year Yield-on-Cost % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mosaic ImmunoEngineering's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Mosaic ImmunoEngineering's 5-Year Yield-on-Cost % falls into.


Mosaic ImmunoEngineering 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Mosaic ImmunoEngineering is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Mosaic ImmunoEngineering (CPMV) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 01, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Mosaic ImmunoEngineering and its competitors. According to the industry distribution chart, Mosaic ImmunoEngineering ranks #999999 out of 150 companies in the Biotechnology industry.
Is Mosaic ImmunoEngineering's 5-Year Yield-on-Cost % too high?
Mosaic ImmunoEngineering's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Mosaic ImmunoEngineering ranks #999999 out of 150 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Mosaic ImmunoEngineering's 5-Year Yield-on-Cost % compare to TCRT and JAGX?
According to the Biotechnology industry distribution chart, Mosaic ImmunoEngineering ranks #999999 out of 150 companies for 5-Year Yield-on-Cost %. This places Mosaic ImmunoEngineering in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.71. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.71, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Mosaic ImmunoEngineering and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mosaic ImmunoEngineering's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mosaic ImmunoEngineering stock overvalued right now?
Mosaic ImmunoEngineering (CPMV) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Mosaic ImmunoEngineering (CPMV), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mosaic ImmunoEngineering Business Description

Address 9114 Adams Avenue, Suite 202, Huntington Beach, CA, USA, 92646
Mosaic ImmunoEngineering Inc is a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. It has a single operating segment for the purposes of assessing performance and making operating decisions. The company is pursuing new product candidates and platforms to build a product pipeline based on its deep understanding of immunotherapies.